Ecotoxicity of carbamazepine and its UV photolysis transformation products

Science of the Total Environment

Volumn 443, Issue , 2013, Pages 870-876

  Donner, Erica ^a,b   Kosjek, Tina ^c   Qualmann, Signe ^d   Kusk, Kresten Ole ^d   Heath, Ester ^c   Revitt, D Michael ^b   Ledin, Anna ^d   Andersen, Henrik Rasmus ^d  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b MIDDLESEX UNIVERSITY   (United Kingdom)

^c JO EF STEFAN INSTITUTE   (Slovenia)

^d TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Acridine; Acridone; Carbamazepine; Environment; Pharmaceuticals; Toxicity

Indexed keywords

ACRIDINE; ACRIDONES; CARBAMAZEPINE; DEGRADATION PRODUCTS; ECOTOXICITY; ENVIRONMENT; ENVIRONMENTAL RISKS; MIXTURE TOXICITY; NATURAL WATERS; PARENT COMPOUNDS; PHARMACEUTICAL AGENTS; PHARMACEUTICAL COMPOUNDS; PHOTOINDUCED DEGRADATION; SINGLE COMPOUND; TOXICITY TESTING; TRANSFORMATION PRODUCTS; ULTRAVIOLET PHOTOLYSIS; UV PHOTOLYSIS; WASTEWATER EFFLUENTS;

AMIDES; DEGRADATION; DRUG PRODUCTS; EFFLUENTS; MIXTURES; PHOTOLYSIS; WASTEWATER TREATMENT;

TOXICITY;

ACRIDINE; ACRIDONE DERIVATIVE; CARBAMAZEPINE;

DRUG; ECOTOXICOLOGY; EFFLUENT; ENVIRONMENTAL RISK; PHOTODEGRADATION; PHOTOLYSIS; TOXICITY; TRANSFORMATION; WASTEWATER;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DAPHNIA MAGNA; ECOTOXICITY; EFFLUENT; ENVIRONMENTAL MANAGEMENT; ENVIRONMENTAL MONITORING; LIGHT EXPOSURE; NONHUMAN; PHOTODEGRADATION; PHOTOLYSIS; PHOTOOXIDATION; PRIORITY JOURNAL; PSEUDOKIRCHNERIELLA SUBCAPITATA; TOXICITY TESTING; ULTRAVIOLET RADIATION; VIBRIO FISCHERI; WASTE COMPONENT REMOVAL;

ANTICONVULSANTS; CARBAMAZEPINE; ENVIRONMENTAL POLLUTANTS; PHOTOCHEMISTRY; SOLID PHASE EXTRACTION; ULTRAVIOLET RAYS;

ALGAE; CRUSTACEA;

EID: 84870786568     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2012.11.059     Document Type: Article

References (59)

1. Agüera A., Pérez-Estrada L.A., Ferrer I., Thurman E.M., Malato S., Fernández-Alba A.R. Application of time-of-flight mass spectrometry to the analysis of phototransformation products of diclofenac in water under natural sunlight. J Mass Spectrom 2005, 40:908-915.
2. Andreozzi R., Marotta R., Paxéus N. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environments. Chemosphere 2003, 50:1319-1330.
3. Besse J.-P., Garric J. Human pharmaceuticals in surface waters: implementation of a prioritization methodology and application to the French situation. Toxicol Lett 2008, 176:104-123.
4. Bleeker E.A.J., van der Geest H.G., Kraak M.H.S., de Voogt P., Admiraal W. Comparative ecotoxicity of NPAHs to larvae of the midge Chironomus riparius. Aquat Toxicol 1998, 41:51-62.
5. Bleeker E.A.J., van der Geest H.G., Klamer H.J.C., de Voogt P., Wind E., Kraak M.H.S. Toxic and genotoxic effects of azaarenes: isomers and metabolites. Polycycl Aromat Compd 1999, 13:191-203.
6. Broos K., MJ Warne, Heemsbergen D.A., Stevens D., Barnes M.B., Correll R.L., et al. Soil factors controlling the toxicity of Cu and Zn to microbial processes in Australian soils. Environ Toxicol Chem 2007, 26:583-590.
7. Calza P., Medana C., Padovano E., Giancotti V., Baiocchi C. Identification of the unknown transformation products derived from clarithromycin and carbamazepine using liquid chromatography/high-resolution mass spectrometry. Rapid Commun Mass Spectrom 2012, 26:1687-1704.
8. Christensen E.R., Kusk K.O., Nyholm N. Dose-response regressions for algal growth and similar continuous endpoints: calculation of effective concentrations. Environ Toxicol Chem 2009, 28:826-835.
9. Clara M., Strenn B., Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res 2004, 38:947-954.
10. Clara M., Strenna B., Gans O., Martinez E., Kreuzinger N., Kroissa H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res 2005, 39:4797-4807.
11. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 2002, 142:185-194.
12. Cooney J.D., Gehrs C.W. Effects of temperature, feeding and acridine on development and mortality of eggs and nauplii of Diaptomus clavipes Schacht. Aquat Toxicol 1984, 5:197-209.
13. DellaGreca M., Fiorentino A., Iesce M.R., Isidori M., Nardelli A., Previtera L., et al. Identification of phototransformation products of prednisone by sunlight: toxicity of the drug and its derivatives on aquatic organisms. Environ Toxicol Chem 2003, 22(3):534-539.
14. Dijkman N.A., van Vlaardingen P.L.A., Admiraal W.A. Biological variation in sensitivity to N-heterocyclic PAHs: effects of acridine on seven species of micro-algae. Environ Pollut 1997, 95:121-126.
15. Doll T.E., Frimmel F.H. Fate of pharmaceuticals - photodegradation by simulated solar UV-light. Chemosphere 2003, 52:1757-1769.
16. Eisentraeger A., Brinkmann C., Hollert H., Sagner A., Tiehm A., Neuwoehner J. Heterocyclic compounds: toxic effects using algae, daphnids, and the Salmonella/microsome test taking methodological quantitative aspects into account. Environ Toxicol Chem 2008, 27:1590-1596.
17. Escher B.I., Fenner K. Recent advances in environmental risk assessment of transformation products. Environ Sci Technol 2011, 45:3835-3847.
18. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., McArdell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res 2011, 45:75-92.
19. Falås P., Andersen H.R., Ledin A., Jansen J.L.C. Occurrence and reduction of pharmaceuticals in the water phase at Swedish wastewater treatment plants. Water Sci Technol 2012, 783-791.
20. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals, a review. Aquat Toxicol 2006, 76:122-159.
21. Ferrari B., Paxéus N., Lo Giudice R., Pollio A., Garric J. Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotoxicol Environ Saf 2003, 55:359-370.
22. 2 treatment of estrogenic chemicals in biologically treated sewage. Int J. Photoenergy 2012, 10.1155/2012/270320.
23. Hansen K., Andersen H.R., Kosjek T., Heath E., Kaas P., Ledin A. Photolysis and advanced oxidation treatment of pharmaceuticals in tap water and treated sewage. Sixth international conference on technologies for waste and wastewater treatment - Energy from waste - Remediation of contaminated sites - Emissions related to climate, November 26-28, 2007. Proceedings 2007, vol. 2:791-798. Kalmar University, Kalmar, Sweden.
24. Heberer T., Mechlinski A., Fanck B., Knappe A., Massmann G., Pekdeger A., et al. Field studies on the fate and transport of pharmaceutical residues in bank filtration. Groundwater Monit Remediat 2004, 24:70-77.
25. Hernando M.D., Mezcua M., Fernández-Alba A.R., Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 2006, 69:334-342.
26. Hey G., Ledin A., Jansen J.L.C., Andersen H.R. Oxidation of pharmaceuticals by chlorine dioxide in biologically treated wastewater. Chem Eng J 2012, 185-186:236-242.
27. Huber M.M., Göbel A., Joss A., Hermann N., Löffler D., McArdell C.S., et al. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ Sci Technol 2005, 39:4290-4299.
28. International Standard Organisation.ISO6341. Water quality - Determination of the inhibition of the mobility of Daphnia magna Straus (Cladocera, Crustacea) - Acute toxicity test 1996, International Organization for Standardization, Switzerland.
29. International Standard Organisation.ISO11348-3. Water quality - Determination of the inhibitory effect of water samples on the light emission of Vibrio fischeri (Luminescent bacteria test) - Part 3: method using freeze-dried bacteria 1998, International Organization for Standardization, Switzerland.
30. International Standard Organisation.ISO8692. Water quality - Freshwater algal growth inhibition test with unicellular green algae 2004, International Organisation for Standardisation, Switzerland.
31. Jos A., Repetto G., Rios J.C., Hazen M.J., Molero M.L., del Peso A., et al. Ecotoxicological evaluation of carbamazepine using six different model systems with eighteen endpoints. Toxicol In Vitro 2003, 17:525-532.
32. 2 advanced oxidation. Environ Sci Technol 2012, 46:6222-6227.
33. Kim Y., Choi K., Jung J., Park S., Kim P.G., Park J. Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ Int 2007, 370-375.
34. Kosjek T., Andersen H.R., Kompare B., Ledin A., Heath E. Fate of carbamazepine during water treatment. Environ Sci Technol 2009, 43:6256-6261.
35. Kosjek T., Perko S., Zupanc M., Zanoški H.M., Landeka D.T., Žigon D., et al. Environmental occurrence, fate and transformation of benzodiazepines in water treatment. Water Res 2011, 46:355-368.
36. Kraak M.H.S., Ainscough C., Fernandez A., van Vlaardingen P.L.A., de Voogt P., Admiral W.A. Short-term and chronic exposure of the zebra mussel (Dreissena polymorpha) to acridine: effects and metabolism. Aquat Toxicol 1997, 37:9-20.
37. Kümmerer K. The presence of pharmaceuticals in the environment due to human use - present knowledge and future challenges. J Environ Manage 2009, 90:2354-2366.
38. Kümmerer K. Antiobiotics in the aquatic environment - A review - Part I. Chemosphere 2009, 75:417-434.
39. Lacey C., Basha S., Morrissey A., Tobin J.M. Occurrence of pharmaceutical compounds in wastewater process streams in Dublin, Ireland. Environ Monit Assess 2012, 184:1049-1062.
40. Li Z., Fenet H., Gomez E., Chiron S. Transformation of the antiepileptic drug oxycarbamazepine upon different water disinfection processes. Water Res 2011, 45:1587-1596.
41. Lürling M., Sargant E., Roessink I. Life-history consequences for Daphnia pulex exposed to pharmaceutical carbamazepine. Environ Toxicol 2006, 21:172-180.
42. Macova M., Escher B.I., Reungoat J., Carswell S., Chue K.L., Keller J., et al. Monitoring the biological activity of micropollutants during advanced wastewater treatment with ozonation and activated carbon filtration. Water Res 2010, 44:477-492.
43. Mayer P., Cuhel R., Nyholm N. A simple in vitro fluorescence method for biomass measurements in algal growth inhibition tests. Water Res 1997, 31:2525-2531.
44. Metcalfe C.D., Miao X.S., Koenig B.G., Struger J. Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower great lakes, Canada. Environ Toxicol Chem 2003, 22:2881-2889.
45. Ollers S., Singer H.P., Fassler P., Muller S.R. Simultaneous quantification of neutral and acidic pharmaceuticals and pesticides at the low ng/l level in surface and waste water. J Chromatogr A 2001, 911:225-234.
46. Parkhurst B.R., Bradshaw A.S., Forte J.L., Wright G.P. The chronic toxicity to Daphnia magna of acridine, a representative azaarene present in synthetic fossil fuel products and wastewaters. Environ Pollut 1981, 24:21-30.
47. Parolini M., Quinn B., Binelli A., Provini A. Cytotoxicity assessment of four pharmaceutical compounds on the zebra mussel (Dreissena polymorpha) haemocytes, gill and digestive gland primary cell cultures. Chemosphere 2011, 84:91-100.
48. Quinn B., Gagne F., Blaise C. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarians, Hydra attenuate. Sci Total Environ 2008, 389:306-314.
49. Rao K.R., Belorkar N. Development and validation of a specific stability indicating liquid chromatographic method for carbamazepine in bulk and pharmaceutical dosage forms. J Adv Pharm Res. 2010, 1:36-47.
50. Rizzo L., Meric S., Guida M., Kassinos D., Belgiorno V. Heterogenous photocatalytic degradation kinetics and detoxification of an urban wastewater treatment plant effluent contaminated with pharmaceuticals. Water Res 2009, 43:4070-4078.
51. Scheytt T., Mersmann P., Lindstadt R., Heberer T. Determination of sorption coefficients of pharmaceutically active substances carbamazepine, diclofenac, and ibuprofen, in sandy sediments. Chemosphere 2005, 60:245-253.
52. Schulze T., Weiss S., Schymanski E., von der Ohe P.C., Schmitt-Jansen M., Altenburger R., et al. Identification of a phytotoxic photo-transformation product of diclofenac using effect-directed analysis. Environ Pollut 2010, 1461-1466.
53. Southworth G.R., Beauchamp J.J., Schmieder P.K. Bioaccumulation potential and acute toxicity of synthetic fuel effluents in freshwater biota: azaarenes. Environ Sci Technol 1978, 12:1062-1066.
54. Stackelberg P.E., Furlong E.T., Meyer M.T., Zaugg S.D., Hendersond A.K., Reissmand D.B. Persistence of pharmaceutical compounds and other organic wastewater contaminants in a conventional drinking water treatment plant. Sci Total Environ 2004, 329:99-113.
55. Stackelberg P.E., Gibbs J., Furlong E.T., Meyer M.T., Zaugg S.D., Lippincott R.L. Efficiency of conventional drinking water treatment processes in removal of pharmaceuticals and other organic compounds. Sci Total Environ 2007, 377:255-272.
56. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res 1998, 32:3245-3260.
57. Ternes T.A., Meisenheimer M., McDowell D., Sacher F., Brauch H.J., Haist-Guide B., et al. Removal of pharmaceuticals during drinking water treatment. Environ Sci Technol 2002, 36:3855-3863.
58. Togola A., Budzinski H. Multi-residue analysis of pharmaceutical compounds in aqueous samples. J Chromatogr A 2008, 1177:150-158.
59. von Gunten U. Ozonation of drinking water: part I. Oxidation kinetics and product formation. Water Res 2003, 37:1443-1467.